InnoCore’s SynBiosys® polymeric technology platform enables customizable, long-acting drug release up to 12 months; ideal for complex peptide and biologic APIs requiring precise control, scalability, and reliable therapeutic performance.
The technology is proven and well differentiated from other platforms, and supports a wide range of advanced injectable, biodegradable dosage forms, including microspheres, implants and in-situ forming depots.